EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions

Nishit Joshi, Bhupesh Vaidya, Shyam Sunder Sharma iD

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Nishit Joshi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Transient Receptor Potential Channels. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 186 Literaturangaben. Gefördert von: Cognitive Science Research Initiative, Department of Science & Technology (DST), New Delhi, India, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a devastating disorder with a multifaceted aetiology characterized by dementia, which later progresses to cognitive impairment. Significant efforts have been made to develop pharmacological interventions that slow down the pathogenesis of AD. However, conventional drugs have failed to satisfactorily treat AD and are more focussed towards symptomatic management. Thus, there is a gap in the literature regarding novel targets and modulators targeting them for the effective treatment of AD. Recent studies have demonstrated that modulation of transient receptor potential (TRP) channels has the potential to halt AD pathogenesis at an early stage and rescue hippocampal neurons from death. Amongst several members, TRP channels like TRPA1, TRPC6, TRPM2 and TRPV2 have shown promising results in the attenuation of neurobehavioural cognitive deficits as well as signalling pathways governing such cognitive decline. Furthermore, as these channels govern the ionic balance in the cell, their beneficial effects have also been known to maintain the homeostasis of Ca 2+ , which is the major culprit eliciting the vicious cycle of excitotoxicity, mitochondrial dysfunction, ROS generation and neurodegeneration. Despite such tremendous potential of TRP channel modulators, their clinical investigation remains elusive. Therefore, in the present review, we have discussed such agents in the light of TRP channels as molecular targets for the amelioration of AD both at the preclinical and clinical levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTransient Receptor Potential ChannelsHumansAnimalsMolecular Targeted TherapySignal TransductionNeurons

Stichwörter der Autor:innen

ADPRAlzheimer's diseaseTRPcognitive impairmentoxidative stress

Substanzen

Transient Receptor Potential Channels

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, India.

ORCID-Profile: Shyam Sunder Sharma

Förderung

  • Cognitive Science Research Initiative, Department of Science & Technology (DST), New Delhi, India
  • Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India

Zitieren

APA

Joshi, N., Vaidya, B., & Sharma, S. S. (2024). Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14073

Vancouver

Joshi N, Vaidya B, Sharma SS. Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14073

BibTeX
@article{Joshi2024,
  author = {Joshi, Nishit and Vaidya, Bhupesh and Sharma, Shyam Sunder},
  title = {Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14073}
}
Kostenlos starten →